1-10 of 10
Eva Nievergall
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Addition of Isatuximab to Lenalidomide, Bortezomib and Dexamethasone As Induction Therapy for Newly-Diagnosed, Transplant-Eligible Multiple Myeloma Patients: The Phase III GMMG-HD7 Trial

Hartmut Goldschmidt, Elias K Mai, Eva Nievergall, Roland Fenk, Uta Bertsch, Diana Tichy, Britta Besemer, Jan Dürig, Roland Schroers, Ivana v. Metzler, Mathias Haenel, Christoph Mann, Anne-Marie Asemissen, Bernhard Heilmeier, Stefanie Huhn, Katharina Kriegsmann, Niels Weinhold, Steffen P. Luntz, Tobias A. W. Holderried, Karolin Trautmann-Grill, Deniz Gezer, Maika Klaiber-Hakimi, Martin Mueller, Cyrus Khandanpour, Wolfgang Knauf, Markus Munder, Thomas Geer, Hendrik Riesenberg, Joerg Thomalla, Martin Hoffmann, Marc-Steffen Raab, Hans Salwender, Katja Weisel
Journal: Blood
Blood (2021) 138 (Supplement 1): 463.
https://doi.org/10.1182/blood-2021-145097
Published: 2021
Journal Articles

Absence of NKG2D Ligands Defines Human Acute Myeloid Leukaemia Stem Cells and Mediates Their Immune Evasion

Anna M Paczulla, PhD, Kathrin Rothfelder, PhD, Simon Raffel, MD, Martina Konantz, PhD, Julia Steinbacher, PhD, Hui Wang, PhD, Marcelle Ndoh Mbarga, Thorsten Schaefer, PhD, Daniela Dörfel, MD, Mattia Falcone, Eva Nievergall, PhD, Claudia Tandler, MSc, Christoph Lutz, Pontus Lundberg, PhD, Lothar Kanz, Leticia Quintanilla-Martinez, MD, Alexander Steinle, Andreas Trumpp, Prof, PhD, Helmut R. Salih, MD, Claudia Lengerke, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 769.
https://doi.org/10.1182/blood-2018-99-118047
Published: 2018
Journal Articles

High Prevalence of Relapse in Australian Children with Ph-like Acute Lymphoblastic Leukemia Despite Risk Adapted Treatment

Susan L Heatley, PhD MD, Teresa Sadras, PhD, Eva Nievergall, PhD, Chung Hoow Kok, PhD, Phuong Dang, BSci (Hon), Kelly Quek, PhD, Nicola C Venn, Sarah Moore, BSc (Hon), FFSc (RCPA), Tamara Law, BSc (Hons), Anthea Ng, BAppSc, MSc, Murray D Norris, PhD, Tamas Revesz, MD PhD, Michael P Osborn, MBBS, Chris Fraser, FRACP, MBBS, MPH, Frank Alvaro, MBBS, FRACP, Glenn M Marshall, MBBS, MD FRACP, Luciano Dalla Pozza, MBBS, FRACP, Timothy P. Hughes, MD MBBS, FRACP, FRCPA, Charles G. Mullighan, MBBS, MSc, MD, Rosemary Sutton, PhD, Deborah L White, PhD FFSc (RCPA)
Journal: Blood
Blood (2015) 126 (23): 1419.
https://doi.org/10.1182/blood.V126.23.1419.1419
Published: 2015
Journal Articles

High Plasma Levels of TGF-α and IL-6 at Diagnosis Predict Early Molecular Response Failure and Transformation in CML

Eva Nievergall, PhD, John Reynolds, PhD, Chung H Kok, PhD, Dale Watkins, PhD, Mark Biondo, PhD, Samantha J Busfield, PhD, Gino Vairo, PhD, David T Yeung, BSc, MBBS, FRACP, FRCPA, Angel Lopez, PhD, Devendra K Hiwase, MBBS, MD PhD FRACP, FRCPA, Deborah L White, PhD FFSc (RCPA), Timothy P Hughes, MD MBBS, FRACP, FRCPA
Journal: Blood
Blood (2014) 124 (21): 1788.
https://doi.org/10.1182/blood.V124.21.1788.1788
Published: 2014
Journal Articles

Monoclonal antibody targeting of IL-3 receptor α with CSL362 effectively depletes CML progenitor and stem cells

Eva Nievergall, Hayley S. Ramshaw, Agnes S. M. Yong, Mark Biondo, Samantha J. Busfield, Gino Vairo, Angel F. Lopez, Timothy P. Hughes, Deborah L. White, Devendra K. Hiwase
Journal: Blood
Blood (2014) 123 (8): 1218–1228.
https://doi.org/10.1182/blood-2012-12-475194
Published: 2014
Includes: Supplemental data
Journal Articles

STAT5 Is a Critical Component Of The Time-Dependent Sensitivity Of CML Cells To TKI Treatment In a Bcr-Abl-Dependent, But JAK2-Independent Manner

Lisa Schafranek, BSc., (Hons), Eva Nievergall, PhD, Jason A. Powell, BSc, PhD, Devendra K. Hiwase, MBBS, MD, PhD, FRACP, FRCPA, Deborah L. White, PhD, FFSc(RCPA), Timothy P. Hughes, MD, MBBS, FRACP, FRCPA, Tamara Leclercq, PhD
Journal: Blood
Blood (2013) 122 (21): 2705.
https://doi.org/10.1182/blood.V122.21.2705.2705
Published: 2013
Journal Articles

Effective Elimination of CML Progenitor and Stem Cells Through Combination of α-CD123 Antibody-Dependent Cell-Mediated Cytotoxicity and Tyrosine Kinase Inhibitor Treatment

Eva Nievergall, PhD, Deborah L. White, PhD, FFSc(RCPA), Agnes S.M. Yong, MD, PhD, Hayley S. Ramshaw, PhD, Samantha J. Busfield, PhD, Gino Vairo, PhD, Angel F. Lopez, MBBS, PhD, Timothy P. Hughes, MD, MBBS, Devendra K. Hiwase, MBBS, MD, PhD, FRACP, FRCPA
Journal: Blood
Blood (2012) 120 (21): 32.
https://doi.org/10.1182/blood.V120.21.32.32
Published: 2012
Journal Articles

Commitment of CML Cells to Apoptotic Cell Death Depends On the Length of Exposure to Das and the Level of STAT5 Activity

Lisa Schafranek, BSc., (Hons), Eva Nievergall, PhD, Jason A Powell, PhD, Devendra K. Hiwase, MBBS, MD, PhD, FRACP, FRCPA, Deborah L. White, PhD, FFSc(RCPA), Timothy P. Hughes, MD, MBBS
Journal: Blood
Blood (2012) 120 (21): 3736.
https://doi.org/10.1182/blood.V120.21.3736.3736
Published: 2012
Journal Articles

Antibody-Targeting of IL-3 Receptor-α Increases the Susceptibility of CD34 + CML Progenitors to Dasatinib-Induced Cell Death,

Eva Nievergall, Deborah L. White, PhD. FFSc(RCPA), Hayley Ramshaw, PhD, Angel F. Lopez, MBBS, PhD, Timothy P. Hughes, MD, MBBS, Devendra K Hiwase, MBBS, MD, PhD, FRACP, FRCPA
Journal: Blood
Blood (2011) 118 (21): 3745.
https://doi.org/10.1182/blood.V118.21.3745.3745
Published: 2011
Journal Articles

Elevated protein tyrosine phosphatase activity provokes Eph/ephrin-facilitated adhesion of pre-B leukemia cells

Sabine H. Wimmer-Kleikamp, Eva Nievergall, Kristina Gegenbauer, Samantha Adikari, Mariam Mansour, Trina Yeadon, Andrew W. Boyd, Neill R. Patani, Martin Lackmann
Journal: Blood
Blood (2008) 112 (3): 721–732.
https://doi.org/10.1182/blood-2007-11-121681
Published: 2008
Includes: Multimedia, Supplemental data